Long-term survival of upper tract urothelial carcinoma patients in a tertiary care hospital

Authors

  • Kanrapee Nuwatkrisin Division of Urology, Department of Surgery, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand
  • Takarn Itsaranujareankul Division of Urology, Department of Surgery, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand
  • Kamol Panumatrassamee Division of Urology, Department of Surgery, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand
  • Dutsadee Sowanthip Division of Urology, Department of Surgery, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand
  • Julin Opanuraks Division of Urology, Department of Surgery, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand
  • Supoj Ratchanon Division of Urology, Department of Surgery, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand
  • Apirak Santingamkun Division of Urology, Department of Surgery, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand
  • Manint Usawachintachit Division of Urology, Department of Surgery, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand

DOI:

https://doi.org/10.52786/isu.a.45

Keywords:

Survival analysis, transitional cell carcinoma, upper tract urothelial carcinoma

Abstract

Objective: Upper urinary tract urothelial carcinoma (UTUC) is an uncommon but rapidly progressive disease associated with a high mortality rate. Despite the advancement in surgical and medical treatment during the last decade, long-term clinical data pertinent to UTUC are still limited in Thailand. The objectives of this study were to identify the long-term survival rate and factors affecting the survival of UTUC patients.

Materials and Methods: We reviewed medical records of UTUC patients treated at King Chulalongkorn Memorial Hospital from 2004 to 2019. We calculated 5-year survival rate using the Kaplan-Meier method and investigated its correlation with various clinicopathological factors through the Cox hazard regression model.

Results: One hundred and twenty-seven UTUC patients were included in this study. There was a slight predominance of females (55.1%), and the mean age at diagnosis was 68.2 years. The majority of patients were TNM stage I (43.3%) followed by stage III (26.9%). The 5-year overall and cancer-specific survival rates were 62.2% and 75.6%, respectively. Based on univariable analysis, TNM stage, pathological T stage, pathological N stage, and lymph node dissection status were associated with the overall survival and cancer-specific survival. However, none of these factors remained statistically significant in the multivariate analysis.

Conclusion: The 5-year overall survival rate of UTUC patients was 62.2%. TNM stage, pathological T stage, pathological N stage, and lymph node dissection status were associated with the overall survival. A further study with a higher population number is warranted to add weight to these findings and investigate their potential clinical use further.

References

Soria F, Shariat SF, Lerner SP, Fritsche H-M, Rink M, Kassouf W, et al. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol 2017;35:379-87.

Colin P, Koenig P, Ouzzane A, Berthon N, Villers A, Biserte J, et al. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int 2009;104:1436-40.

Margulis V, Shariat SF, Matin SF, Kamat AM, Zi- geuner R, Kikuchi E, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009; 115:1224-33.

Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 update. Eur Urol 2018; 73:111-22.

Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol 2011;29:481-6.

Wheat JC, Weizer AZ, Wolf JS, Lotan Y, Remzi M, Margulis V, et al. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol-Semin Ori 2012;30:252-8.

Raman JD, Messer J, Sielatycki JA, Hollenbeak CS. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005. BJU Int 2011;107:1059-64.

Rimthephathip K WN. Nephroureterectomy for upper urinary tract transitional cell carcinoma in Rajavithi Hospital: Experience in the last 8 years. Thai J Urol 2017;38:31-8.

Wang Q, Zhang T, Wu J, Wen J, Tao D, Wan T, et al. Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China. BMC Urol 2019;19:24.

Favaretto RL, Shariat SF, Chade DC, Godoy G, Adamy A, Kaag M, et al. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 2010;58:574-80.

Munoz JJ, Ellison LM. Upper tract urothelial neo- plasms: incidence and survival during the last 2 decades. J Urol 2000;164:1523-5.

Taweemonkongsap T, Nualyong C, Amornvesukit T, Leewansangtong S, Srinualnad S, Chaiyaprasithi B, et al. Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: comparison of retroperitoneoscopic and open nephroureterectomy. World J Surg Oncol 2008;6:1-7.

Downloads

Published

2022-06-17

How to Cite

Nuwatkrisin, K., Itsaranujareankul, T. ., Panumatrassamee, K. ., Sowanthip, D. ., Opanuraks, J. ., Ratchanon, S. ., Santingamkun, A. ., & Usawachintachit, M. (2022). Long-term survival of upper tract urothelial carcinoma patients in a tertiary care hospital. Insight Urology, 43(1), 25–32. https://doi.org/10.52786/isu.a.45

Issue

Section

Original article